EUVIMEDEUVIMED entdecken
Open Access

Depression modifies age-associated [ 11 C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease

Kyle J Edmunds iD, Alexis R Nelson iD, Talia L Brach, Matthew Glittenberg iD, Bradley T Christian, Tobey J Betthauser iD, Sterling C Johnson, Sanjay Asthana, Ozioma C Okonkwo

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251353098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Kyle J Edmunds und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Depression, Amyloid beta-Peptides, Aging. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depression—especially late-life onset—is associated with age-related cognitive decline and may be a key risk factor for amyloid-β (Aβ) deposition in preclinical Alzheimer's disease (AD).

Objective

This study assesses whether depressive symptoms modify the relationship between age and Aβ burden in a cohort at-risk for AD.

Methods

N = 238 cognitively unimpaired participants from the Wisconsin Alzheimer's Disease Research Center participated in Pittsburgh Compound-B positron emission tomography ( 11 C-PiB-PET), where distribution volume ratio scores were used to quantify Aβ burden in nine regions of interest (ROIs) susceptible to early Aβ burden. Depressive symptoms were assessed using the Geriatric Depression Scale (GDS). Cross-sectional linear regression models examined interactions between age and GDS scores, adjusting for sex, apolipoprotein ε4 ( APOE ε4) carriage, and age difference between PET imaging and GDS assessment. GDS-stratified analyses were performed to test within-group associations between age and 11 C-PiB-PET Aβ aggregation in each ROI, and item-level analyses identified specific depressive symptoms that modified these relationships.

Results

Participants had a mean age of 68.0 years (SD ± 8.4), 39.7% were APOE ε4 carriers, 64% were female, and 85.3% were White. GDS scores were largely normal (M = 1.29, SD = 1.61). Age × GDS interactions were significant across all ROIs, and stratified models revealed progressively stronger associations as GDS scores increased. Finally, item-level analyses identified the second and tenth GDS items as significant modifiers across six ROIs and the global composite.

Conclusions

In a cohort enriched with risk for AD, emerging depressive symptoms amplified the association between age and Aβ burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDepressionAmyloid beta-PeptidesAgingBrainHumansFemaleMalePositron-Emission TomographyAgedAniline CompoundsThiazolesCohort StudiesAged, 80 and overCross-Sectional StudiesMiddle AgedApolipoprotein E4Carbon Radioisotopes

Stichwörter der Autor:innen

Alzheimer's disease[11C]PiB-PET imagingagingamyloid-βgeriatric depression

Substanzen

2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAniline CompoundsThiazolesAmyloid beta-PeptidesApolipoprotein E4Carbon Radioisotopes

Autor:innen und Institutionen

  • Department of Medicine and Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Institute of Biomedical and Neural Engineering (IBNE), Reykjavík University, Reykjavík, Iceland.
  • Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.

ORCID-Profile: Kyle J Edmunds, Alexis R Nelson, Matthew Glittenberg, Tobey J Betthauser

Förderung

  • NIA NIH HHS
  • NIH HHS
  • NCRR NIH HHS
  • NICHD NIH HHS
  • National Institute on Aging
  • National Center for Advancing Translational Sciences
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institutes of Health

Zitieren

APA

Edmunds, K. J., Nelson, A. R., Brach, T. L., Glittenberg, M., Christian, B. T., Betthauser, T. J., Johnson, S. C., Asthana, S., & Okonkwo, O. C. (2025). Depression modifies age-associated [ 11 C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251353098

Vancouver

Edmunds KJ, Nelson AR, Brach TL, Glittenberg M, Christian BT, Betthauser TJ, et al. Depression modifies age-associated [ 11 C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251353098

BibTeX
@article{Edmunds2025,
  author = {Edmunds, Kyle J and Nelson, Alexis R and Brach, Talia L and Glittenberg, Matthew and Christian, Bradley T and Betthauser, Tobey J and Johnson, Sterling C and Asthana, Sanjay and Okonkwo, Ozioma C},
  title = {Depression modifies age-associated [ 11 C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251353098}
}
Kostenlos starten →